Search

everythinglearnresearchcommunity

for

Search:↓

Certain immune cells contribute to severe hair loss in chronic alopecia areata, with Th17 cells possibly having a bigger impact than cytotoxic T cells.

New treatments for Alopecia Areata show promise but need to be more effective and affordable.

Both vitiligo and alopecia areata involve an immune response triggered by stress and specific genes, with treatments targeting this pathway showing potential.

Tofacitinib can temporarily improve hair growth in alopecia universalis, but its effectiveness may decrease over time.

Researchers developed a new way to measure gene activity in single hair follicles and found that a specific gene's activity changes with different amounts and times of treatment.

People with alopecia areata have more Th17 cells and fewer Treg cells, which may be key to the condition's development.

The document concludes that managing side effects of MS therapies is crucial for treatment success and patient adherence.

A woman and her daughter had thallium poisoning from a herbal drink and rodenticide, causing hair loss and other symptoms.

Trichoscopy helped diagnose and treat a woman with two different types of hair loss.

UK medical students lack dermatology education, liver biopsy patients with risk factors show more fibrosis, and certain fungi resist drugs due to melanin; genetics may influence female hair loss.

Skin problems are common after stem cell transplants, and early treatment by dermatologists can improve patient outcomes.

Patients with advanced breast cancer and high hormone receptor levels who had surgery for ovarian/pelvic metastases lived longer, especially if they had high estrogen receptor levels.

Chronic inflammatory skin diseases are caused by disrupted interactions between skin cells and immune cells.

Hair and nail conditions can stabilize or improve over time, and new treatments show promise.

Costunolide may have multiple health benefits, including promoting hair growth and protecting against cancer and diabetes, but more research is needed.

Male hormones worsen kidney transplant damage, but blocking them helps.

Freezing gamma-irradiated amniotic fluid may help hair growth and speed up the growth phase.

New treatments for Alopecia Areata, like JAK inhibitors, show promise for hair regrowth and are likely to change future treatment approaches.

Prolactin affects the production of different keratins in human hair, which could lead to new treatments for skin and hair disorders.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

Gray hair can potentially be reversed, leading to new treatments.

Oral tofacitinib can significantly improve recalcitrant lichen planopilaris.

Hair follicles in people with alopecia have lower levels of a key blood vessel growth protein.

Clascoterone is a new, effective, and safe acne treatment without systemic side effects.

Hair color production in mice is closely linked to the hair growth phase and may also influence hair growth itself.

Topical JAK inhibitors may help treat some skin conditions but need more research.

Tofacitinib citrate is effective for moderate-to-severe chronic plaque psoriasis but has safety concerns at higher doses.

New treatments for a chronic skin condition show promise, but individualized plans are crucial due to varying responses.

Pregnancy can change skin disease severity, with some conditions improving and others worsening, and treatment should balance benefits and fetal safety.

Oral tofacitinib may effectively treat hair loss in children with alopecia areata.